Soligenix Announces Positive Clinical Results From a Comparative Study Evaluating Hybryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma
Soligenix宣佈了一項比較研究中Hybryte™與Valchlor®在治療皮膚T細胞淋巴瘤方面的積極臨床結果。
Soligenix Announces Positive Clinical Results From a Comparative Study Evaluating Hybryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma
Soligenix宣佈了一項比較研究中Hybryte™與Valchlor®在治療皮膚T細胞淋巴瘤方面的積極臨床結果。
譯文內容由第三人軟體翻譯。